TE VA 7630 (Imatinib Mesylate 400 mg)
Pill with imprint TE VA 7630 is Brown, Capsule-shape and has been identified as Imatinib Mesylate 400 mg. It is supplied by Teva Pharmaceuticals USA, Inc..
Imatinib is used in the treatment of chronic myelogenous leukemia; gastrointestinal stromal tumor; chronic eosinophilic leukemia; myeloproliferative disorders; acute lymphoblastic leukemia (and more), and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Imatinib 400 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TE VA 7630
Imatinib Mesylate
- Imprint:
- TE VA 7630
- Strength:
- 400 mg
- Color:
- Brown
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- BCR-ABL tyrosine kinase inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Teva Pharmaceuticals USA, Inc.
- National Drug Code (NDC):
- 00093-7630
More about imatinib
- Imatinib Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 36 Reviews
- Drug class: BCR-ABL tyrosine kinase inhibitors
Consumer resources
Other brands: Gleevec
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
